Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.

AusPAR: Methotrexate

Australian Public Assessment Report

AusPAR

AusPAR: Methotrexate [PDF, 729.44 KB]

AusPAR: Methotrexate [Word, 546.92 KB]

Attachment: Product Information: Methotrexate [PDF, 285.37 KB]

Attachment: Product Information: Methotrexate [Word, 72.89 KB]

Attachment: Product Information: Methotrexate [PDF, 292.84 KB]

Attachment: Product Information: Methotrexate [Word, 76.43 KB]

Attachment: Extract from Clinical Evaluation Report: Methotrexate [PDF, 1.29 MB]

Attachment: Extract from Clinical Evaluation Report: Methotrexate [Word, 1.99 MB]

Device/Product Name

TREXJECT / TREXJECT IN

Active ingredients

Methotrexate

AusPAR Date

7 June 2017

Published

15 June 2017

Submission Number

PM-2014-01050-1-3

Submission Type

Major variation (new presentation, new route of administration)

Decision

Approved